Barr body frequency in the human breast cancer tissue. A prospective study on its prognostic value and its correlation with specific oestradiol receptors
Rajeswari, S.; Ghosh, S.N.; Shah, P.N.; Borah, V.J.
European Journal of Cancer 13(2): 99-102
1977
ISSN/ISBN: 0014-2964 PMID: 852491 Document Number: 433887
This communication describes the study on the Barr body frequency from 93 tumor specimens. It appears that this biological determinant provides an accurate and reliable prediction of the clinical course of the disease in a given patient. Analysis of Barr body frequency vis-a-vis estradiol receptors in 50 unselected breast cancer tissues did not reveal any significant correlation.
Document emailed within 1 workday
Related Documents
Griniatsos, J.; Diamantis, E.; Gioti, J.; Karyda, I.; Vassilopoulos, P.P.; Agnanti, N. 1998: Correlation of prostate specific antigen immunoactivity (IR-PSA) to other prognostic factors in female breast cancer Anticancer Research 18(1b): 683-688Tomica, D.; Ramić, S.; Danolić, D.; Knezević, F.; Kolak, T.; Balja, M.P.ć; Alvir, I.; Mamić, I.; Puljiz, M. 2014: A correlation between the expression of estrogen receptors and progesterone receptors in cancer cells and in the myometrium and prognostic factors in endometrial cancer Collegium Antropologicum 38(1): 129-134
Bonneterre, J.; Peyrat, J.P.; Beuscart, R.; Demaille, A. 1990: Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer Cancer Research 50(21): 6931-6935
Memon, I.; Given, F. 1986: Correlation of oestrogen receptors with prognostic indices in primary breast carcinoma Irish Medical Journal 79(4): 90-93
Gumus, M.; Yumuk, P.F.; Salepci, T.; Aliustaoglu, M.; Dane, F.; Ekenel, M.; Basaran, G.; Kaya, H.; Barisik, N.; Turhal, N.S. 2006: HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples Journal of Experimental and Clinical Cancer Research: Cr 25(4): 515-521
Fernö, M.; Borg, A. 1985: Antiestrogen binding sites in human breast cancer biopsies. Measurement ligand-specificity and affinity, and correlation to estrogen and progesterone receptors Anticancer Research 5(3): 307-312
Tsyrlina, E.V.; Semiglazov, V.P.; Moiseenko, V.M.; Bornoeva, T.P. 1985: Study of the role of steroid receptors in human breast cancer Neoplasma 32(4): 463-467
Ngamkham, J.; Homcha-Aim, P.; Boonmark, K.; Phansri, T.; Swangvaree, S.S. 2013: Preliminary study on human papillomavirus frequency and specific type-distribution in vulva cancer from Thai women Asian Pacific Journal of Cancer Prevention: Apjcp 14(4): 2355-2359
Yamashita, J.; Ogawa, M.; Beppu, T. 1993: Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines Research Communications in Chemical Pathology and Pharmacology 82(2): 249-252
Foekens, J.A.; Portengen, H.; van Putten, W.L.; Trapman, A.M.; Reubi, J.C.; Alexieva-Figusch, J.; Klijn, J.G. 1989: Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer Cancer Research 49(24 Part 1): 7002-7009
Brdar, B.; Graf, D.; Padovan, R.; Nola, P.; Rudan, N.; Petrinec, Z.; Sarcević, B.; Belicza, M. 1988: Estrogen and progesterone receptors as prognostic factors in breast cancer Tumori 74(1): 45-52
Thorpe, S.M.; Rose, C.; Rasmussen, B.B.; King, W.J.; DeSombre, E.R.; Blough, R.M.; Mouridsen, H.T.; Rossing, N.; Andersen, K.W. 1986: Steroid hormone receptors as prognostic indicators in primary breast cancer Breast Cancer Research and Treatment 7 Suppl: S91-S97
Liu, Q.; Wang, X.Z.; Mu, D.B.; Li, T.Y.; Liu, Y.S.; Yu, Z.Y. 2015: Correlation analysis of hormone receptors and the expressions of HER-2 and Ki-67 in breast cancer European Journal of Gynaecological Oncology 36(1): 78-83
Younes, M.; Brown, R.W.; Mody, D.R.; Fernandez, L.; Laucirica, R. 1995: GLUT1 expression in human breast carcinoma: correlation with known prognostic markers Anticancer Research 15(6b): 2895-2898
Conde, I.; Paniagua, R.; Fraile, B.; Ruiz, A.; Arenas, M.I. 2004: Expression of vitamin D3 receptor and retinoid receptors in human breast cancer: identification of potential heterodimeric receptors International Journal of Oncology 25(4): 1183-1191
Thorpe, S.M. 1987: Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors Cancer Research 47(7): 1830-1835
Haase, W. 1995: Tissue CEA as a prognostic factor in patients with breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(2): 117-118
Zhang, Y.; Ma, A.D.; Jia, H.X. 2016: Correlation between molybdenum target mammography signs and pathological prognostic factors of breast cancer Journal of Biological Regulators and Homeostatic Agents 30(1): 219-225
Goussia, A.; Agnantis, N.J.; Athanassiadou, S.; Stefanou, D. 1995: Prognostic significance of C-erbB-2 and hormone receptors' status in human benign and malignant breast lesions Anticancer Research 15(5b): 2313-2318
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176